Cargando…
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients
High grade non-muscle-invasive bladder tumours are treated with transurethral resection followed by recurrent intravesical instillations of Bacillus Calmette Guérin (BCG). Although most bladder cancer patients respond well to BCG, there is no clinical parameter predictive of treatment response, and...
Autores principales: | Castellano, Eva, Samba, Célia, Esteso, Gloria, Simpson, Laura, Vendrame, Elena, García‐Cuesta, Eva M., López‐Cobo, Sheila, Álvarez-Maestro, Mario, Linares, Ana, Leibar, Asier, Ranganath, Thanmayi, Reyburn, Hugh T., Martínez‐Piñeiro, Luis, Blish, Catherine, Valés‐Gómez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520259/ https://www.ncbi.nlm.nih.gov/pubmed/36189320 http://dx.doi.org/10.3389/fimmu.2022.970931 |
Ejemplares similares
-
CyTOF(®) for the Masses
por: Iyer, Akshay, et al.
Publicado: (2022) -
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine
por: Ashiru, Omodele, et al.
Publicado: (2019) -
Removing unwanted variation with CytofRUV to integrate multiple CyTOF datasets
por: Trussart, Marie, et al.
Publicado: (2020) -
Cytomulate: accurate and efficient simulation of CyTOF data
por: Yang, Yuqiu, et al.
Publicado: (2023) -
An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data
por: Crowell, Helena L., et al.
Publicado: (2022)